Psychological problems in men experiencing cancer
the ONA take:
According to new research presented at the Annual Conference of the British Psychological Society's Division of Clinical Psychology in Glasgow, Scotland, researchers from the University of St Andrews in St Andrews, Scotland, have identified markers for vulnerability to psychological issues in men with cancer.
For the study, researchers enrolled 127 men aged 18 years and older with cancer between April 2009 and April 2011. Researchers assessed the participants for anxiety, demographic factors, depression, and social support. The data for cancer patients was then compared to the Scottish Longitudinal Study to ensure that the sample was representative of men with cancer.
Results showed that participants who were separated or divorced had decreased social support and more depression.
In addition, younger participants had higher anxiety and distress. Residing in an area of higher deprivation also resulted in increased anxiety and depression. Furthermore, social support was identified as a key indicator for psychological health.
The findings suggest that men with cancer who lack social support are more vulnerable to depression. The researchers note that more further studies are warranted to confirm these results, but this study begins to fill a gap in this area of the literature.
Researchers identified markers for vulnerability to psychological issues in men with cancer.
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Adding Bevacizumab to Adjuvant Capecitabine Not Effective for mCRC
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|